Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Opioids

June 11, 2021 | Daily News

Some Democratic senators told HHS Secretary Xavier Becerra during committee hearings this week they were pleased to see large increases in funding to tackle opioid and substance use disorder in the fiscal 2022 budget request, but they asked for additional support on funding cliffs and opioid production solutions.

May 28, 2021 | Daily News

CMS requests $16.3 million for opioid and substance use disorder support services in its fiscal 2022 budget -- a nearly $13 million increase from the 2021 enacted level -- indicating CMS wants to prioritize tackling the substance abuse crisis this year.

May 24, 2021 | Daily News

Former FDA chief Scott Gottlieb and former HHS Assistant Secretary for Health Brett Giroir sparred over the safety of kratom and who’s to blame for the lack of strict scheduling, coming just minutes after FDA announced the seizure of $1.3 million worth of kratom-containing dietary supplements and bulk dietary ingredients.

May 18, 2021 | Daily News

HHS on Tuesday (May 18) said the Substance Abuse and Mental Health Services Administration (SAMHSA) will distribute $3 billion from the American Rescue Plan to support mental health and substance abuse services, as data show drug overdoses climbed and more Americans reported high levels of anxiety during the pandemic.

May 12, 2021 | Daily News

House Majority Leader Steny Hoyer (D-MD) next week will bring back to the House floor a bipartisan bill that aims to close a loophole in the Orphan Drug Act, after Republicans blocked the bill’s passage Tuesday evening (May 11) due to a fallout between the measure’s lead Democratic sponsor and former GOP co-sponsor Rep. Buddy Carter (GA).

May 05, 2021 | Daily News

President Joe Biden signed into law Tuesday (May 4) a temporary extension of the class-wide Schedule 1 classification of fentanyl-like substances.

April 27, 2021 | Daily News

The Biden administration on Tuesday (April 27) removed some of the prescribing barriers for buprenorphine, a drug used to treat opioid use disorder, after initially pulling back a proposed Trump administration guideline that would have relaxed the barriers in January.

April 21, 2021 | Daily News

The House passed a bill Wednesday (April 21) to authorize a five-month extension on emergency scheduling of fentanyl-like substances, which classifies the analogues as Schedule 1 drugs.

April 19, 2021 | Daily News

Lawmakers from both parties are interested in reducing barriers to medication-assisted treatment for substance use disorders, though some Republican lawmakers said at a House Energy & Commerce health subcommittee hearing last week that expanding access to treatment without comprehensive care plans would not be productive.

April 15, 2021 | Daily News

Several House Republicans said at a hearing Wednesday (April 14) that Congress should pass legislation to either extend or make permanent the Schedule 1 classification for fentanyl-related substances, while some Democrats touted an opposing bill that would use harm-reduction strategies to tackle the fentanyl crisis.

April 09, 2021 | Daily News

President Joe Biden’s fiscal year 2022 discretionary budget preview, released Friday (April 9), builds off health priorities in the recently enacted American Rescue Plan and proposed American Jobs Plan by calling for additional funding for home- and community-based services, tackling the opioid crisis, rural health and more.

April 07, 2021 | Daily News

Stakeholders are hoping to see methadone administration flexibilities continued after the COVID-19 public health emergency, a request that could be in reach after the Biden administration said last Thursday (April 1) it will review methadone treatment policies and develop recommendations to modernize them.

March 12, 2021 | Daily News

The American Psychological Association CEO advocated for increased funding for mental health and substance abuse treatment and prevention, better enforcement of mental health parity laws and racial equity in treatment at a House Appropriations subcommittee hearing on COVID-19 and the mental health and substance use crises Thursday (March 11).

March 04, 2021 | Daily News

The COVID-19 pandemic has overshadowed policymakers’ attention to the opioid and substance use disorder crisis, stakeholders say, but provisions included in COVID-19 relief legislation are a good start in recognizing the connection between the two public health emergencies.

February 10, 2021 | Daily News

The Pew Charitable Trusts and 15 other medical and advocacy organizations want Democratic and GOP congressional leaders to remove from the law certain training requirements for doctors who want to prescribe buprenorphine to treat opioid use disorder.

January 26, 2021 | Daily News

The Biden administration reportedly plans to pull back a buprenorphine prescribing guideline that was announced by HHS in the last days of the Trump administration and would exempt physicians from certain certification requirements needed to prescribe buprenorphine for opioid use disorder.

January 14, 2021 | Daily News

HHS is exempting physicians from certain certification requirements needed to prescribe buprenorphine for opioid use disorder, the department announced Thursday (Jan. 14).

October 29, 2020 | Daily News

The Pew Charitable Trusts unveiled a report earlier this month (Oct. 20) detailing ways states could expand access to naloxone, an opioid overdose-reversing drug, as state and local reports show overdoses are on the rise this year.

October 05, 2020 | Daily News

FDA’s risk mitigation programs for fentanyl and extended-release opioids are not suited to quickly address the opioid crisis, according to the HHS Office of Inspector General, which released a report Tuesday (Sept. 29) recommending the agency improve the programs.

October 02, 2020 | Daily News

A new Bipartisan Policy Center report on the opioid crisis says the federal government should do a better job using its opioid funds to target at-risk groups and should revisit Medicaid practices that restrict access to treatment.

Pages